For research and educational purposes only. Not medical advice.
Ipamorelin Reference
Educational, not medical advice reference for Ipamorelin: GH Release, Sleep; regulatory status, evidence posture, source review, and schedule notes. Also kno…
Reference summary
Early human PK/PD work in healthy volunteers confirmed GH release across dose levels, while older preclinical pharmacology emphasized relative selectivity versus older GHRPs. Long-term clinical outcome data remain limited.
- Categories
- GH Release, Sleep
- Aliases
- Ipamorelin acetate
- Evidence posture
- human — Small short-term endocrine studies only. Long-term outcome data are limited.
- Regulatory status
- No FDA-approved ipamorelin drug label. FDA lists ipamorelin acetate among bulk substances with safety-risk concerns for compounding.
- Content review status
- research reference